Figure 1.
Impact of cetuximab on overall survival in patients with (A) RAS/BRAF V600E wild type metastatic colorectal cancer compared to best supportive care in the CO.17 trial and stratified by (B) molecular subgroup.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.